- Home
- SGU vs TERN Comparison
SGU vs TERN Comparison
Compare SGU & TERN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SGU
- TERN
- Stock Information
- Founded
- SGU 1995
- TERN 2017
- Country
- SGU United States
- TERN United States
- Employees
- SGU N/A
- TERN N/A
- Industry
- SGU Other Specialty Stores
- TERN Biotechnology: Pharmaceutical Preparations
- Sector
- SGU Consumer Discretionary
- TERN Health Care
- Exchange
- SGU Nasdaq
- TERN Nasdaq
- Market Cap
- SGU 399.4M
- TERN 382.2M
- IPO Year
- SGU 1995
- TERN 2021
- Fundamental
- Price
- SGU $12.45
- TERN $4.58
- Analyst Decision
- SGU
- TERN Buy
- Analyst Count
- SGU 0
- TERN 5
- Target Price
- SGU N/A
- TERN $18.30
- AVG Volume (30 Days)
- SGU 31.5K
- TERN 1.9M
- Earning Date
- SGU 02-05-2025
- TERN 03-13-2025
- Dividend Yield
- SGU 5.70%
- TERN N/A
- EPS Growth
- SGU 10.70
- TERN N/A
- EPS
- SGU 0.90
- TERN N/A
- Revenue
- SGU $1,766,099,000.00
- TERN N/A
- Revenue This Year
- SGU N/A
- TERN N/A
- Revenue Next Year
- SGU N/A
- TERN N/A
- P/E Ratio
- SGU $13.08
- TERN N/A
- Revenue Growth
- SGU N/A
- TERN N/A
- 52 Week Low
- SGU $9.64
- TERN $4.17
- 52 Week High
- SGU $12.93
- TERN $11.40
- Technical
- Relative Strength Index (RSI)
- SGU 51.54
- TERN 36.30
- Support Level
- SGU $11.65
- TERN $4.17
- Resistance Level
- SGU $12.26
- TERN $4.75
- Average True Range (ATR)
- SGU 0.34
- TERN 0.29
- MACD
- SGU 0.04
- TERN 0.03
- Stochastic Oscillator
- SGU 50.98
- TERN 27.89
About SGU Star Group L.P.
Star Group LP is a company engaged in providing home heating products and services to residential and commercial customers. The company offers heating oil and air conditioning equipment, as well as home security and plumbing services. The company also sells diesel fuel, gasoline, and home heating oil. Geographically, the company operates in U.S.
About TERN Terns Pharmaceuticals Inc.
Terns Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company is developing a portfolio of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis, NASH, and other chronic liver diseases.